TRAFFIC, a Retrievable and Scalable Cell Encapsulation Device for the treatment of type 1 diabetes
Type 1 diabetes patients are at risk of both hyperglycemia and hypoglycemia events. Transplanting insulin-producing islet cells into a type 1 diabetes (T1D) patient to produce insulin is an alternative to insulin therapy. But the administration of the long-term immunosuppressive drug is required in the islet transplanting technique. Another method is transplanting them into the human organ after coating and encapsulating insulin-producing islet cells into hundreds of thousands of tiny hydrogel capsules. But there are a tumour or tumor risks with the failed or dead transplanted islet cells in the body and they should be removed. Removing thousands of failed or dead tiny capsules from the human organ is not an easy task.
Researchers have developed an ingenious method for the treatment of type I diabetes in a patient. They successfully designed a potentially game-changing medical device named as TRAFFIC (Thread-Reinforced Alginate Fiber For Islets enCapsulation). In this new device, researchers coated islet cells with a thin hydrogel and attached all of them to a polymer thread called as TRAFFIC. With this device
Transplantation of six feet of TRAFFIC containing insulin-producing islet cells into the peritoneal cavity of the type 1 diabetes (T1D) patient requires a minimally invasive laparoscopic surgical procedure.
Researchers have conducted experiments to check blood glucose or sugar control among mice models with type 1 diabetes (T1D) by implanting one-inch length of TRAFFIC. They observed normal glucose levels within two days. They also found continuous normal blood sugar or glucose levels for at least three months.
They have conducted another experiment with dog models to check removal and replacement of TRAFFIC. Researchers were successful in implanting and removing 10-inch TRAFFIC from its body. They used laparoscopic surgery (also called as minimally invasive surgery) in this process. They have conducted these surgical experiments with multiple devices and found minimal stickiness between the surrounding tissue and the device.
Following are the major features in the technique involved in TRAFFIC device.
The device has got patent protection and the study has got support from the following organizations.
Co-lead authors of the research group were Duo An and Alan Chiu, Doctoral students. The leader of the research group was Minglin Ma, an Assistant Professor, Department of Biological and Environmental Engineering, College of Agriculture and Life Sciences, Cornell University, Ithaca, New York. The study findings were published December 25, 2017, in the Proceedings of the National Academy of Sciences. Title of the paper was "Designing a Retrievable and Scalable Cell Encapsulation Device for Potential Treatment of Type 1 Diabetes."
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.